No Summary

Johnson & Johnson CFO Says Guidance Hike Is Just the Start - Barron's

Johnson & Johnson CFO Says Guidance Hike Is Just the Start

Sources

• Johnson & Johnson CFO Says Guidance Hike Is Just the Start — Barron's
• Tremfya surges, Icotyde gains ground as J&J raises bar for 2026 — FirstWord PHARMA
• No patent protection for Stelara? No problem for J&J as Tremfya fills the void — Fierce Pharma
• Johnson & Johnson Bumps Up Guidance as Sales Rise — WSJ
• J&J medtech miss overshadows earnings beat — Reuters